Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 10, 2016 12:57 PM ET

Company Overview of National Taiwan University

Company Overview

National Taiwan University is an educational institution.

Taipei,  

Taiwan

Founded in 1928

Key Executives for National Taiwan University

National Taiwan University does not have any Key Executives recorded.

National Taiwan University Key Developments

Agilis Biotherapeutics and National Taiwan University Enter into Worldwide, Exclusive License Agreement for the Gene Therapy Treatment of AADC Deficiency

Agilis Biotherapeutics, LLC announced that the company has entered into an exclusive worldwide license agreement with National Taiwan University (NTU) for the treatment of Aromatic L-Amino Acid (AADC) Deficiency using gene therapy developed by Dr. Paul Hwu, Professor of Pediatrics at NTU Hospital. AADC Deficiency is a rare CNS disorder arising from a reduction in the enzyme, aromatic L-amino acid decarboxylase (AADC), caused by mutations in the dopa decarboxylase (DDC) gene. This reduction leads to deficits in the neurotransmitters dopamine, norepinephrine, epinephrine, serotonin and melatonin. In its profound forms, AADC Deficiency causes severe developmental delays, the inability to develop motor strength and control (global muscular hypotonia/dystonia) resulting in breathing, feeding, and swallowing problems, frequent hospitalizations, and the need for life-long care that ultimately culminates in premature death within the first decade of life. In an effort to address the high unmet medical need in AADC patients, Dr. Hwu and colleagues have developed a novel gene therapy targeted to restore deficient AADC and have successfully treated 18 subjects in two prospective clinical studies. Under the terms of the agreement with NTU, Agilis will sponsor ongoing research and development of the AADC gene therapy in collaboration with Dr. Hwu, including the conduct of ongoing clinical work on AADC gene therapy and completion of nonclinical testing in advance of the pivotal clinical study, anticipated to begin in 2017. Agilis will also support ongoing manufacturing efforts for the gene therapy.

National Taiwan University Presents at Bit's 5th New Energy Forum-2015, Sep-26-2015 11:35 AM

National Taiwan University Presents at Bit's 5th New Energy Forum-2015, Sep-26-2015 11:35 AM. Venue: China. Speakers: Ching-Fuh Lin, Director & Distinguished Professor, Innovative Photonics Advanced Research Center.

Similar Private Companies By Industry

Company Name Region
Kinmen Kaoliang Liquor Inc. Asia
Hua Xiang Development Ltd. Asia
Kao Shin Commercial Bank Asia
Pynmax Technology Co., Ltd. Asia
Wei Sheng Investment Corp. Asia

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact National Taiwan University, please visit www.ntu.edu.tw. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.